GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
860

am I the only one who found triple agonist harder than the injections

Results Clean Column ×7

Confession thread, sort of.

I went from 0.25mg to 10mg much faster than I should have because the scale had stalled and I got impatient. The stall broke about 14 weeks later, at which point I had no way of knowing whether the dose increase did anything or whether it would have broken anyway.

So now I have constipation I did not need and a data point I cannot interpret. Two lessons in one.

Posting it in the hope that somebody at week 43 reads it before doing the same thing.

1,396 up / 536 down72% upvoted53 commentsid 1dx8cd29 Oct 2025

53 comments

21 in this archive, depth 5

best — the order this archive was captured in

u/hassan_nilsen111 points·9 months ago

research use only, handling and analysis, not protocols

replysharereportpermalink
u/cagrilintide_enthusiast93 points·9 months ago

This is the "correlation is mechanism" thing again. You changed three variables at once.

replysharereportpermalink
u/nikhil_lindqvist59 points·9 months ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink
u/reta_and_regretMOD62 points·9 months ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
u/deleted_my_history47 points·9 months ago

research use only, handling and analysis, not protocols

replysharereportpermalink
u/farid_molnar-18 points·9 months ago

Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.

replysharereportpermalink
u/careful_gradient321 point·9 months ago·edited

This is correct. Triple agonism is genuinely different.

replysharereportpermalink
u/source_or_silence1 point·9 months ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink
u/solene_ilunga1 point·9 months ago·edited

research use only, handling and analysis, not protocols

replysharereportpermalink
u/solene_ilunga59 points·9 months ago·edited

The glucagon component does different things than dual agonism. The early fullness are not just amplified versions.

replysharereportpermalink
u/careful_gradient3235 points·9 months ago

No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.

replysharereportpermalink
u/devils_advocate_d22 points·9 months ago

No.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/ferran_krastev26 points·9 months ago

the 12.5mg arm is different from 15mg, results do not transfer

replysharereportpermalink
u/lurker_for_years20 points·9 months ago·edited

Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.

replysharereportpermalink
u/nikhil_asante15 points·9 months ago
source?
replysharereportpermalink
u/zeynep_mbeki12 points·9 months ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink
u/janek_ferrari10 points·9 months ago·edited

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
u/heart_rate_bump11 points·9 months ago

Slight fix: the number was 97.6, not 97.9. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/farid_molnar5 points·9 months ago

Slight fix: the number was 97.6, not 97.9.

Disagree on that part. 98.4% and 98.3% on the same vial is normal.

replysharereportpermalink
load more comments (1) →
u/hugo_pires14 points·9 months ago
^ this
replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.